These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7791066)

  • 41. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
    Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
    Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
    Johnson RN; Olsen KR; Hernandez E
    Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.
    Zalta AH; Sweeney CP; Zalta AK; Kaufman AH
    Arch Ophthalmol; 2002 Nov; 120(11):1487-93. PubMed ID: 12427061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vitreous hemorrhage after vitrectomy in diabetic retinopathy and tissue plasminogen activator].
    Asensio Sánchez VM; Pérez Flández FJ; Carlos Bejarano J; Fernández Concellón L
    Arch Soc Esp Oftalmol; 2002 Jan; 77(1):7-12. PubMed ID: 11813114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant tissue plasminogen activator following paediatric cataract surgery.
    Mehta JS; Adams GG
    Br J Ophthalmol; 2000 Sep; 84(9):983-6. PubMed ID: 10966949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.
    Lundy DC; Sidoti P; Winarko T; Minckler D; Heuer DK
    Ophthalmology; 1996 Feb; 103(2):274-82. PubMed ID: 8594514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Simultaneously corneal laceration repair, traumatic cataract removal and intraocular lens implantation].
    Xiang Q; Liu S; Xu X; Tan Q; Wu X; Ma W
    Yan Ke Xue Bao; 2000 Dec; 16(4):249-51, 278. PubMed ID: 12579781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tissue plasminogen activator treatment of postvitrectomy pupillary fibrin membrane].
    Maeno T; Maeda N; Ikeda T; Tano Y
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1124-8. PubMed ID: 1759654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anterior chamber hemorrhage during cataract surgery in Lowe syndrome.
    Spierer A; Desatnik H
    Metab Pediatr Syst Ophthalmol (1985); 1998; 21(1-4):19-21. PubMed ID: 11548790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Traumatic hyphema caused by eye injuries].
    Luksza L; Homziuk M; Nowakowska-Klimek M; Glasner L; Iwaszkiewicz-Bilikiewicz B
    Klin Oczna; 2005; 107(4-6):250-1. PubMed ID: 16118929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrous ingrowth with retrocorneal membrane.
    Bloomfield SE; Jakobiec FA; Iwamoto T
    Ophthalmology; 1981 May; 88(5):459-65. PubMed ID: 7267021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.
    Hong BK; Francis BA
    Digit J Ophthalmol; 2013; 19(2):21-3. PubMed ID: 24109245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue plasminogen activator for preserving inferior peripheral iridectomy patency in eyes with silicone oil.
    MacCumber MW; McCuen BW; Toth CA; Ferrone PJ; Jaffe GJ
    Ophthalmology; 1996 Feb; 103(2):269-73. PubMed ID: 8594513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
    Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
    Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
    Wollensak G; Meyer JH; Löffler KU; Funk J
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):43-6. PubMed ID: 8965477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
    Zwaan J; Latimer WB
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intraocular complications after severe chemical burns--incidence and surgical treatment].
    Kuckelkorn R; Kottek A; Reim M
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):86-92. PubMed ID: 7967411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound biomicroscopy in the assessment of penetrating or blunt anterior-chamber trauma.
    Genovesi-Ebert F; Rizzo S; Chiellini S; Romani A; Gabbriellini G; Sartini MS; Nardi M
    Ophthalmologica; 1998; 212 Suppl 1():6-7. PubMed ID: 9730736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.
    Ibramsah AB; Cheong AI; Wan Muda WN; Ibrahim M
    Rom J Ophthalmol; 2022; 66(1):27-31. PubMed ID: 35531461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.